Displays of aggressive outbursts portray a mental illness known as
the Intermittent Explosive Disorder.
This disorder, unfortunately, is also believed to be linked with inflammation,
according to a blood test analysis by researchers.
Inflammation is the term used to describe the
body’s effort to keep it safe from the attacks of pathogens. When body is
threatened, it reacts by inflating the particular body part, and begins the
healing process.’ [You can find out more about inflammation at http://benthamsciencepublishers.blogspot.com/2013/12/inflammation-innate-immune-system.html
In fact, according to a study by Dr. Stephen H Boyle of Duke
University Medical Center in Durham, North Carolina, recurring outbursts of
anger might have a biological basis. People who have been diagnosed with this
condition suffer repeated episodes of aggressive behavior. They often lose control over trivial things
and react with violent outbursts, like hurting people physically, throwing
things around and vandalizing property.
Researchers and scientists advocate that increased levels of
C-reactive protein and Interleukin-6 are indicators of possible inflammation in
blood. These two are also believed to have strong connection with impulsive and
aggressive behavior in people. There is a cause and effect relationship between
inflammation and IED.
A number of methods are available for the treatment of Intermittent
Explosive Disorder or IED, such as medication and behavioral therapy. Seeking
treatment is important for the patient as opposed to keeping up with their
hostile treatment of family and friends. Moreover, inflammation also put people
at risk for other medical complications such as heart attack, arthritis and
stroke.
One of the latest additions in the field is “Inflammation & Allergy - Drug Targets”,
a popular research journal published by one of the leading STM publishers in
the industry, Bentham Science Publishers. The journal aims to cater to the discovery, identification,
characterization and validation of novel human drug targets for
anti-inflammation and allergy drug discovery continues to grow, this journal
has become essential reading for all pharmaceutical scientists involved in drug
discovery and development.
0 comments:
Post a Comment